Allopregnanolone ( DrugBank: Allopregnanolone )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 205 | 脆弱Ｘ症候群関連疾患 | 1 |
205. 脆弱Ｘ症候群関連疾患
臨床試験数 : 5 / 薬物数 : 13 - (DrugBank : 7) / 標的遺伝子数 : 25 - 標的パスウェイ数 : 29
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02603926 (ClinicalTrials.gov) | October 2015 | 5/11/2015 | Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone | Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone | Fragile X-associated Tremor/Ataxia Syndrome | Drug: Allopregnanolone | Randi J. Hagerman, MD | NULL | Completed | 50 Years | 85 Years | All | 6 | Phase 2 | United States |